Unmet challenges in HIV therapy and potential of stampidine.
Uckun
Fatih M
FM
Parker Hughes Institute, Roseville, Minnesota, USA.
D000818:Animals; D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D054306:Dideoxynucleotides; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D018119:Stavudine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D013938:Thymidine Monophosphate / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D019380:Anti-HIV Agents; D054306:Dideoxynucleotides; D018894:Reverse Transcriptase Inhibitors; C472384:stampidine; D013938:Thymidine Monophosphate; D018119:Stavudine